Glucagon-like peptide 1 (GLP-1) as a regulator of food intake and body weight: therapeutic perspectives
It requires a needle, which may lead to anxiety or discomfort, especially for individuals with a fear of needles
the participant recovered and completed the trial without further events
Strong bones are the foundation of a healthy, active life, yet the connection between GLP-1 medications and bone density hasnt gotten the same attention as the effect on muscles
The release of inflammatory mediators during infection or as a consequence of abnormal immune signalling pathways, increases the risk of microbial translocation
[DOI] [PubMed] [Google Scholar] 40.Kagawa M, Machida Y, Nishi H, Haginaka J